ArticleBMC cancer2018

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.

Chang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.